BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12516255)

  • 21. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
    Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
    J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hand ultrasound for osteoporosis screening in postmenopausal women.
    Benitez CL; Schneider DL; Barrett-Connor E; Sartoris DJ
    Osteoporos Int; 2000; 11(3):203-10. PubMed ID: 10824235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of quantitative ultrasound in predicting osteoporosis defined by dual-energy X-ray absorptiometry in pre- and postmenopausal women.
    Dane C; Dane B; Cetin A; Erginbas M
    Climacteric; 2008 Aug; 11(4):296-303. PubMed ID: 18645695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined clinical risk indices with quantitative ultrasound calcaneus measurement for identifying osteoporosis in Thai postmenopausal women.
    Pongchaiyakul C; Panichkul S; Songpatanasilp T
    J Med Assoc Thai; 2007 Oct; 90(10):2016-23. PubMed ID: 18041418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A non-invasive prevention program model for the assessment of osteoporosis in the early postmenopausal period: a pilot study on FRAX(®) and QUS tools advantages.
    Villa P; Lassandro AP; Moruzzi MC; Amar ID; Vacca L; Di Nardo F; De Waure C; Pontecorvi A; Scambia G
    J Endocrinol Invest; 2016 Feb; 39(2):191-8. PubMed ID: 26141076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does quantitative ultrasound imaging enhance precision and discrimination?
    Frost ML; Blake GM; Fogelman I
    Osteoporos Int; 2000; 11(5):425-33. PubMed ID: 10912845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How well do radiographic absorptiometry and quantitative ultrasound predict osteoporosis at spine or hip? A cost-effectiveness analysis.
    Lippuner K; Fuchs G; Ruetsche AG; Perrelet R; Casez JP; Neto I
    J Clin Densitom; 2000; 3(3):241-9. PubMed ID: 11090231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is calcaneal quantitative ultrasound useful as a prescreen stratification tool for osteoporosis?
    Thomsen K; Jepsen DB; Matzen L; Hermann AP; Masud T; Ryg J
    Osteoporos Int; 2015 May; 26(5):1459-75. PubMed ID: 25634771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone ultrasound and diagnosis of osteoporosis: correlation of 2 quantitative ultrasound methods with bone density].
    Goerres G; Altermatt M; Müller-Brand J; Tyndall A; Theiler R
    Praxis (Bern 1994); 1998 Aug; 87(35):1089-95. PubMed ID: 9782747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative ability of heel quantitative ultrasound in postmenopausal women with prevalent low-trauma fractures: application of optimal threshold cutoff values using CART models.
    Navarro Mdel C; Saavedra P; Gómez-de-Tejada MJ; Suárez M; Hernández D; Sosa M
    J Clin Densitom; 2011; 14(4):492-8. PubMed ID: 22051094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of computed digital absorptiometry and conventional dual-energy X-ray absorptiometry in postmenopausal women.
    Fiter J; Nolla JM; Gómez-Vaquero C; Martínez-Aguilá D; Valverde J; Roig-Escofet D
    Osteoporos Int; 2001; 12(7):565-9. PubMed ID: 11527054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High correlation between quantitative ultrasound and DXA during 7 years of follow-up.
    Trimpou P; Bosaeus I; Bengtsson BA; Landin-Wilhelmsen K
    Eur J Radiol; 2010 Feb; 73(2):360-4. PubMed ID: 19135327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative ultrasound and symptomatic vertebral fracture risk in Chinese women.
    Kung AW; Luk KD; Chu LW; Tang GW
    Osteoporos Int; 1999; 10(6):456-61. PubMed ID: 10663345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of calcaneal quantitative ultrasound for determining bone mass of the hip.
    Pfister AK; Starcher V; Welch C
    W V Med J; 2003; 99(2):71-3. PubMed ID: 12874917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcaneal ultrasound bone densitometry is not a useful tool to screen patients with inflammatory bowel disease at high risk for metabolic bone disease.
    Schwartz DA; Connolley CD; Koyama T; Wise PE; Herline AJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):749-54. PubMed ID: 16043991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nomogram for predicting osteoporosis risk based on age, weight and quantitative ultrasound measurement.
    Pongchaiyakul C; Panichkul S; Songpatanasilp T; Nguyen TV
    Osteoporos Int; 2007 Apr; 18(4):525-31. PubMed ID: 17216132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is time since hip fracture influencing the discrimination between fractured and nonfractured subjects as assessed at the calcaneum by three technologically different quantitative ultrasound devices?
    Hans D; Allaoua S; Genton L; Delmi M; Vuagnat H; Rizzoli R; Tahintzi-Zawadynski S; Perron C; Pichard C; Slosman DO
    Calcif Tissue Int; 2002 Dec; 71(6):485-92. PubMed ID: 12232682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reference curve and diagnostic sensitivity for a new ultrasound device for the phalanges [correction of phalanages], the DBMsonic 1200, in Belgian women.
    Joly J; Westhovens R; Borghs H; Peeters H; Tirry J; Nijs J; Dequeker J
    Osteoporos Int; 1999; 9(4):284-9. PubMed ID: 10550444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: the four-year effects of hormone replacement therapy.
    Sahota O; San P; Cawte SA; Pearson D; Hosking DJ
    Osteoporos Int; 2000; 11(1):52-8. PubMed ID: 10663359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative ultrasound of the heel as triage test to measure bone mineral density compared with dual energy X-ray absorptiometry in men with prostate cancer commencing with androgen deprivation therapy.
    van Casteren-Messidoro C; Huisman AM; Birnie E; van Gelder M; van de Geijn FE; Hamberg P
    Neth J Med; 2014 Dec; 72(10):528-32. PubMed ID: 26219758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.